[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

The $2.2 Billion Reason Forte BioSciences (FBRX) Stock Is Skyrocketing Today

Forte Biosciences (FBRX) ripped higher on Monday after the Dutch immunology giant, Argenx (ARGX), announced a definitive agreement to acquire it for $2.2 billion. The all-cash transaction is expected to close in the third quarter of 2026 and values FBRX shares at $77 each, representing a huge 40% upside on their previous close.

Following today’s gains, Forte Biosciences stock is trading at more than 3.5x its price at the start of this year. 

Fundamentals

See More
  • Market Capitalization, $K 760,675
  • Shares Outstanding, K 13,886
  • Annual Sales, $ 0 K
  • Annual Income, $ -69,380 K
  • EBIT $ -77 M
  • EBITDA $ -77 M
  • 60-Month Beta 2.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 19.69

Options Overview Details

View History
  • Implied Volatility 23.16% (-171.40%)
  • Historical Volatility 198.61%
  • IV Percentile 1%
  • IV Rank 0.00%
  • IV High 291.19% on 11/06/25
  • IV Low 23.16% on 07/27/26
  • Expected Move (DTE 25) 6.08 (7.94%)
  • Put/Call Vol Ratio 59.10
  • Today's Volume 4,027
  • Volume Avg (30-Day) 418
  • Put/Call OI Ratio 1.87
  • Today's Open Interest 2,005
  • Open Int (30-Day) 1,651
  • Expected Range 70.42 to 82.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.08
  • Number of Estimates 1
  • High Estimate $-1.08
  • Low Estimate $-1.08
  • Prior Year $-0.96
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.95 +283.46%
on 07/06/26
76.60 -0.13%
on 07/27/26
+55.47 (+263.77%)
since 06/26/26
3-Month
15.51 +393.23%
on 06/08/26
76.60 -0.13%
on 07/27/26
+49.70 (+185.45%)
since 04/27/26
52-Week
9.10 +740.66%
on 08/06/25
76.60 -0.13%
on 07/27/26
+64.90 (+559.48%)
since 07/25/25

Most Recent Stories

More News
Stocks Settle Mixed as AI Angst Offsets Easing Geopolitical Tensions

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.32%. September E-mini...

ALK : 47.50 (+2.97%)
SNDK : 1,278.23 (-11.02%)
SLB : 51.53 (-1.70%)
TRI : 97.76 (+8.44%)
FDXF : 150.30 (-4.87%)
OXY : 54.93 (-4.14%)
FANG : 195.80 (-4.34%)
STX : 816.99 (-4.07%)
WDC : 497.92 (-4.21%)
AMD : 494.95 (-5.17%)
SPY : 739.09 (+0.02%)
FBRX : 76.50 (+39.65%)
The $2.2 Billion Reason Forte BioSciences (FBRX) Stock Is Skyrocketing Today

Forte Biosciences stock soars on a $2.2 billion takeover proposal from Argenx. But is there any further upside left in FBRX shares? Let’s find out!

FBRX : 76.50 (+39.65%)
ARGX : 888.82 (-3.20%)
Stocks Fall from Early Highs as Chipmakers Retreat

The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.46%. September E-mini S&P futures...

ALK : 47.50 (+2.97%)
SNDK : 1,278.23 (-11.02%)
OXY : 54.93 (-4.14%)
FANG : 195.80 (-4.34%)
STX : 816.99 (-4.07%)
WDC : 497.92 (-4.21%)
AMD : 494.95 (-5.17%)
SPY : 739.09 (+0.02%)
FBRX : 76.50 (+39.65%)
ADSK : 225.91 (+7.70%)
MU : 900.20 (-2.25%)
BKR : 60.59 (+5.83%)
Stocks Rally as Middle East Tensions Ease

The S&P 500 Index ($SPX ) (SPY ) today is up +0.65%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.56%. September E-mini S&P futures...

ALK : 47.50 (+2.97%)
UAL : 120.57 (+1.94%)
INTU : 303.91 (+2.56%)
CVX : 190.00 (-2.46%)
MBLY : 8.01 (-0.50%)
DDOG : 251.86 (+2.03%)
RKLB : 66.94 (+4.74%)
IONQ : 35.92 (+9.38%)
$IUXX : 28,039.21 (-0.32%)
MPLT : 9.90 (-72.91%)
ZNU26 : 108-170 (-0.04%)
MSFT : 389.10 (+1.94%)
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

FBRX : 76.50 (+39.65%)
Shareholder Alert: Ademi LLP investigates whether Forte Biosciences, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , July 27, 2026 /PRNewswire/ -- Ademi LLP is investigating Forte (Nasdaq: FBRX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

FBRX : 76.50 (+39.65%)
Stocks Set to Open Sharply Higher as Oil Prices Sink, Big Tech Earnings and Fed Meeting in Focus

September S&P 500 E-Mini futures (ESU26) are up +0.98%, and September Nasdaq 100 E-Mini futures (NQU26) are up +1.59% this morning, pointing to a sharply higher open on Wall Street as a slump in oil prices...

GOOGL : 326.56 (+2.13%)
AAPL : 336.91 (+1.17%)
SNDK : 1,278.23 (-11.02%)
CVX : 190.00 (-2.46%)
NQU26 : 28,156.50 (-0.12%)
DLR : 195.76 (-1.67%)
MSFT : 389.10 (+1.94%)
TSLA : 309.22 (-1.22%)
MA : 551.71 (+2.23%)
QCOM : 170.04 (+1.84%)
STX : 816.99 (-4.07%)
V : 362.53 (+1.91%)
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline

Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growth ...

FBRX : 76.50 (+39.65%)
ARGX : 888.82 (-3.20%)
FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

Statistically Significant FB102 Benefit Observed By Day 64 and Continued through Week 24 FB102-Treated Subjects Continued Improving Through Week 24 After Completion of...

FBRX : 76.50 (+39.65%)
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance...

FBRX : 76.50 (+39.65%)

Business Summary

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

See More

Key Turning Points

3rd Resistance Point 76.83
2nd Resistance Point 76.71
1st Resistance Point 76.61
Last Price 76.50
1st Support Level 76.39
2nd Support Level 76.27
3rd Support Level 76.17

See More

52-Week High 76.60
Last Price 76.50
Fibonacci 61.8% 50.81
Fibonacci 50% 42.85
Fibonacci 38.2% 34.88
52-Week Low 9.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.